Phospho-CD5 (Y453) Antibody

What is the Phospho-CD5 (Y453) Antibody and what are its primary research applications?

Phospho-CD5 (Y453) Antibody is a rabbit polyclonal antibody specifically designed to detect endogenous levels of CD5 protein only when phosphorylated at tyrosine residue 453. This antibody is crucial for studying T-cell signaling mechanisms as CD5 is a key regulatory molecule in T-cell receptor (TCR) signaling pathways.

The primary research applications include:

• Western Blot (recommended dilution 1:500-1:2000)

• Immunohistochemistry (recommended dilution 1:100-1:300)

• Immunofluorescence (recommended dilution 1:200-1:1000)

• ELISA (recommended dilution 1:20000)

The antibody has been validated to react with human, mouse, and rat samples, making it versatile for comparative immunology studies across these species .

What is the molecular and cellular significance of CD5 phosphorylation at Y453?

CD5 phosphorylation at Y453 represents a critical regulatory mechanism in T-cell signaling. On its cytoplasmic tail, CD5 contains four tyrosine residues at positions 402, 453, 464, and 486 in humans. While Y402 was initially associated with CD5 inhibitory signaling, mass spectrometry analyses have consistently detected phosphorylation at the three distal tyrosine residues (Y453, Y464, and Y486) .

The Y453 phosphorylation site:

• Is regulated by Src kinases following TCR stimulation

• Serves as a potential docking site for signaling effectors like RasGAP and phosphatidylinositol 3-kinase (PI3K)

• Is critical for CD5's role in negatively regulating TCR signaling

• Contributes to CD5's function in thymocyte selection and T-cell development

Analysis of truncated CD5 mutants demonstrated that the cytoplasmic domain containing these three distal tyrosines (including Y453) accounts for global CD5 phosphorylation and is required for CD5 signaling activity .

How should I design validation experiments to confirm the specificity of a Phospho-CD5 (Y453) Antibody?

Validating the specificity of Phospho-CD5 (Y453) Antibody requires multiple complementary approaches:

1. Phosphatase Treatment Control:

• Split your sample and treat half with lambda phosphatase before immunoblotting

• The phospho-specific signal should disappear in the phosphatase-treated sample while total CD5 remains detectable

2. Stimulation-Dependent Phosphorylation:

• Compare resting T cells with TCR-stimulated T cells

• CD5 tyrosine phosphorylation is maximal approximately 2 minutes after CD3 stimulation and returns to baseline by 60 minutes

• Include time course experiments (0, 2, 5, 15, 30, 60 min) to capture the phosphorylation dynamics

3. Phospho-Peptide Blocking:

• Pre-incubate the antibody with the phospho-peptide immunogen (spanning amino acids 421-470 around pY453)

• This should abolish specific immunoreactivity

4. Knockout/Knockdown Validation:

• Use CD5 knockout cells or CD5 siRNA-treated cells as negative controls

• No signal should be detected in these samples

5. Site-Directed Mutagenesis:

• Express wild-type CD5 and Y453F mutant in a CD5-negative cell line

• Only wild-type CD5 should show phosphorylation upon stimulation

A complete validation protocol would include at least three of these approaches to conclusively demonstrate specificity.

What are the optimal sample preparation methods for detecting phospho-CD5 (Y453) in different experimental settings?

Optimal sample preparation is critical for maintaining phosphorylation status and depends on the experimental technique:

For Western Blotting:

• Use ice-cold lysis buffer containing phosphatase inhibitors (10 mM sodium fluoride, 2 mM sodium orthovanadate, 50 mM β-glycerophosphate)

• Include protease inhibitors to prevent protein degradation

• Maintain samples at 4°C throughout processing

• Avoid multiple freeze-thaw cycles

• Recommended dilution: 1:500-1:2000

For Immunohistochemistry:

• Fix tissues rapidly in phospho-preserving fixatives (preferably 4% paraformaldehyde)

• Avoid long fixation times that may cause epitope masking

• Use phosphatase inhibitors in all buffers

• Consider antigen retrieval methods (citrate buffer pH 6.0 or EDTA buffer pH 8.0)

• Recommended dilution: 1:100-1:300

For Immunofluorescence:

• Fix cells with 4% paraformaldehyde (10 min, room temperature)

• Permeabilize with 0.1% Triton X-100 (5 min)

• Block with 5% BSA containing phosphatase inhibitors

• Maintain cold conditions when possible

• Recommended dilution: 1:200-1:1000

For Cell Stimulation Experiments:

• Stimulate T cells with anti-CD3 antibody or PMA/ionomycin

• Optimal stimulation time for peak Y453 phosphorylation is approximately 2 minutes

• Immediately lyse cells in ice-cold buffer to preserve phosphorylation state

How can Phospho-CD5 (Y453) Antibody be utilized to investigate the role of CD5 in T-cell malignancies?

CD5 is highly expressed in approximately 85% of T-cell malignancies, making phospho-CD5 detection valuable for understanding disease mechanisms and potential therapeutic targets . Advanced research applications include:

Analyzing Signaling Dysregulation:

• Compare phospho-CD5 (Y453) levels between healthy T cells and malignant T-cell lines

• Correlate phosphorylation patterns with disease progression or treatment resistance

• Investigate whether aberrant CD5 phosphorylation contributes to constitutive activation of downstream pathways

Therapeutic Target Identification:

• Use phospho-CD5 (Y453) detection to monitor CD5 activity following treatment with kinase inhibitors

• Evaluate whether CD5-targeting CAR-T cell therapies affect phosphorylation status of remaining CD5+ cells

• Study how Y453 phosphorylation influences CD5's role in T-cell proliferation and survival pathways

Biomarker Development:

• Assess whether phospho-CD5 (Y453) levels correlate with clinical outcomes

• Perform phosphoproteomics in combination with immunohistochemistry to create detailed phosphorylation profiles of different T-cell malignancies

• Track changes in CD5 phosphorylation during disease progression

For example, research on CD5-positive diffuse large B-cell lymphoma (DLBCL) has used proteomics approaches to reveal suppression of B-cell signals, which could inform similar studies in T-cell malignancies using phospho-specific antibodies .

What methodological approaches can resolve contradictory results when studying CD5 phosphorylation in different T-cell subsets?

Contradictory results in CD5 phosphorylation studies often stem from technical and biological variability. Here's a methodological framework to resolve such discrepancies:

1. Standardize Cell Isolation Techniques:

• Use identical isolation protocols for all T-cell subsets

• Minimize activation during isolation (use negative selection methods)

• Rest cells for 1-2 hours post-isolation before stimulation

• Document detailed phenotypic characterization of each subset

2. Control for Baseline CD5 Expression Levels:

• Quantify total CD5 expression in each subset by flow cytometry

• Normalize phospho-CD5 signals to total CD5 expression

• Use dual staining approaches (e.g., flow cytometry with anti-CD5 and anti-phospho-CD5)

3. Address Kinetic Differences:

• Perform detailed time-course experiments (0, 1, 2, 5, 10, 15, 30, 60 minutes)

• Different T-cell subsets may exhibit different phosphorylation kinetics

• Include multiple stimulation conditions (anti-CD3 alone, anti-CD3/CD28, antigen-specific)

4. Employ Multiple Detection Methods:

• Compare results from Western blot, flow cytometry, and mass spectrometry

• Each technique has different sensitivity and specificity profiles

• Use phospho-flow cytometry for single-cell resolution of heterogeneous populations

5. Validate with Genetic Approaches:

• Generate CD5 Y453F knock-in models to confirm antibody specificity

• Use CRISPR-edited primary T cells to validate findings

• Employ phospho-mimetic mutations (Y453E) for functional studies

As noted in the literature, CD5 function differs between thymocytes and mature T cells, and conditional deletion models would help distinguish direct CD5 signaling effects in peripheral T cells from indirect consequences of perturbed thymic selection .

What are the most common technical issues when using Phospho-CD5 (Y453) Antibody in Western blotting and how can they be resolved?

When working with Phospho-CD5 (Y453) Antibody in Western blotting, researchers commonly encounter several technical challenges:

Low or No Signal:

• Cause: Rapid dephosphorylation during sample preparation

• Solution: Ensure phosphatase inhibitors (sodium orthovanadate, sodium fluoride, β-glycerophosphate) are fresh and present in all buffers; maintain samples at 4°C; avoid repeated freeze-thaw cycles

Multiple Bands or Non-specific Binding:

• Cause: Cross-reactivity with other phosphorylated proteins

• Solution: Increase antibody dilution (1:1000-1:2000); optimize blocking conditions (5% BSA is preferred over milk for phospho-antibodies); include longer washing steps; consider using more stringent washing buffers (TBST with 0.1-0.3% Tween-20)

Inconsistent Results Between Experiments:

• Cause: Variable CD5 phosphorylation states or detection sensitivity

• Solution: Standardize cell stimulation protocols; include positive controls (e.g., Jurkat cells stimulated with pervanadate); normalize phospho-signal to total CD5 expression

High Background:

• Cause: Insufficient blocking or excessive antibody concentration

• Solution: Extend blocking time (2 hours at room temperature or overnight at 4°C); use freshly prepared blocking buffer with 5% BSA; ensure thorough washing between antibody incubations

Weak Signal for Expected Molecular Weight:

• Cause: CD5 appears at approximately 67 kDa, but glycosylation can affect migration

• Solution: Use gradient gels (4-15%) to improve resolution; extend transfer time for higher molecular weight proteins; validate with recombinant CD5 protein control

If problems persist, consider using an alternative detection method such as immunoprecipitation followed by Western blotting to enrich for CD5 before probing with the phospho-specific antibody.

How can I distinguish between specific phospho-CD5 (Y453) signal and background in immunofluorescence microscopy?

Distinguishing specific phospho-CD5 (Y453) signals from background in immunofluorescence requires methodical controls and optimization:

Essential Controls:

• Phospho-Peptide Blocking Control:

  • Pre-incubate antibody with the phospho-peptide immunogen

  • This should eliminate specific staining while nonspecific background will remain

  • Images show complete signal blocking when using the phospho-peptide

• Stimulation Control:

  • Compare unstimulated cells (minimal phosphorylation) with TCR-stimulated cells

  • The phospho-signal should increase after stimulation in the correct cellular compartments

  • Phospho-CD5 typically localizes to the immunological synapse upon TCR engagement

• Secondary Antibody-Only Control:

  • Omit primary antibody to identify background from secondary antibody

  • Any signal in this control indicates non-specific binding

Signal Optimization Techniques:

• Fixation Method Comparison:

  • Test different fixatives (4% PFA, methanol, acetone)

  • Phospho-epitopes can be sensitive to fixation conditions

  • Short fixation times (10 minutes) often work best for phospho-epitopes

• Signal Amplification:

  • Use tyramide signal amplification if signal is weak

  • Consider using brightfield techniques (IHC-DAB) as an alternative

  • Optimal dilution range for IF is 1:200-1:1000

• Co-staining Strategy:

  • Co-stain with total CD5 antibody (different species)

  • True phospho-CD5 signal should colocalize with total CD5

  • Include markers for cell compartments (membrane, cytoplasm) to verify localization

Advanced Analytical Approaches:

• Quantitative Analysis:

  • Use software to quantify signal-to-background ratios

  • Measure colocalization coefficients with total CD5

  • Compare intensity across different experimental conditions

• Super-resolution Microscopy:

  • Techniques like STORM or STED can provide better discrimination between specific signal and background

  • Allows visualization of CD5 clusters and phosphorylation patterns at the nanoscale

How does phosphorylation at Y453 affect CD5's interaction with other signaling molecules in T-cell regulation?

Phosphorylation of CD5 at Y453 creates a critical docking site for signaling molecules that mediate CD5's regulatory functions in T cells:

Key Molecular Interactions:

• CBL and CBLB Association:

  • Phospho-Y453 facilitates binding of CBL family proteins

  • This interaction enables CD5 to negatively regulate TCR signaling

  • CBL molecules recruit ubiquitin ligases that downregulate TCR signaling components

  • In thymocytes, CD5 primarily associates with CBL, while mature T cells show interactions with both CBL and CBLB

• PI3K Interaction:

  • Phosphorylated CD5 can recruit phosphatidylinositol 3-kinase (PI3K)

  • This interaction impacts T-cell survival and differentiation pathways

  • The PI3K regulation by ubiquitination is mediated through CBL proteins associated with CD5

• CSK Recruitment:

  • The tyrosine kinase CSK associates with phosphorylated CD5

  • This association was confirmed by co-immunoprecipitation of CSK with CD5 upon TCR stimulation

  • CSK phosphorylates the C-terminal inhibitory tyrosine of Src kinases (particularly Fyn)

  • CD5 ligation induces inhibitory phosphorylation of Fyn, attenuating its activity

• UBASH3A/B Proteins:

  • Ubiquitin-associated and SH3 domain-containing proteins UBASH3A and UBASH3B

  • Associate with CD5 and CBL proteins following TCR stimulation

  • Contribute to negative regulation of TCR signaling through dephosphorylation of positive signaling effectors

Functional Consequences:

The phosphorylation of Y453 serves as a regulatory switch that:

• Promotes CD5's role as a negative regulator of TCR signaling

• Contributes to setting activation thresholds in T cells

• Influences thymocyte selection during T-cell development

• Modulates peripheral T-cell responses to antigen stimulation

These molecular interactions explain why CD5-deficient T cells show enhanced TCR-induced proliferation and cytokine production, highlighting the importance of phospho-Y453 in the inhibitory functions of CD5 .

What is the comparative significance of phosphorylation at Y453 versus other tyrosine residues (Y402, Y464, Y486) in CD5 function?

The four tyrosine residues in CD5's cytoplasmic tail (Y402, Y453, Y464, and Y486) have distinct phosphorylation patterns and functional roles:

Comparative Phosphorylation Patterns:

*Numbers in parentheses represent historical nomenclature when signal peptide sequence is not included

Functional Hierarchy:

Experimental Evidence of Relative Importance:

Mutation studies have shown that:

• The cytoplasmic tail region containing Y453, Y464, and Y486 is required for CD5's inhibitory function

• The three distal tyrosines appear to have partially redundant functions

• Y453 has received particular attention due to its consistent phosphorylation and role in protein-protein interactions

Methodologically, researchers investigating the relative importance of these sites should:

• Generate single and combination Y→F mutants

• Express these in CD5-negative cells

• Assess impact on TCR signaling, protein interactions, and T-cell functions

• Use phospho-specific antibodies to monitor each site independently

How might Phospho-CD5 (Y453) Antibodies be utilized in developing new therapeutic approaches for autoimmune diseases and cancer?

Phospho-CD5 (Y453) Antibodies offer significant potential for developing novel therapeutic strategies through several research avenues:

Diagnostic and Prognostic Applications:

• Develop immunohistochemistry-based assays to classify T-cell lymphomas based on CD5 phosphorylation patterns

• Create companion diagnostics to predict response to therapies targeting T-cell signaling pathways

• Monitor changes in CD5 phosphorylation as a biomarker for disease progression or treatment efficacy

Therapeutic Target Identification:

• Screen small molecule libraries for compounds that selectively modulate CD5 phosphorylation at Y453

• Identify kinases and phosphatases that regulate Y453 phosphorylation as potential drug targets

• Develop therapeutic antibodies that recognize specific CD5 conformations dependent on Y453 phosphorylation status

CAR-T Cell Therapy Enhancement:

• Current CD5-targeting CAR-T cell therapies face challenges with fratricide and limited persistence

• Using phospho-CD5 knowledge to design improved CAR constructs targeting specific CD5 conformations

• Research indicates that CD5 knockout followed by CAR-T modification might overcome fratricidal effects

• Future research could develop CARs that selectively recognize malignant cells based on aberrant CD5 phosphorylation patterns

Autoimmune Disease Applications:

• Investigate CD5 Y453 phosphorylation patterns in autoimmune conditions

• Develop therapies that modulate CD5's inhibitory function to restore T-cell tolerance

• Design peptide inhibitors that interfere with specific CD5 interactions mediated by phospho-Y453

Methodological Considerations for Translational Research:

• Compare phospho-CD5 profiles between patient samples and healthy controls

• Correlate phosphorylation patterns with clinical outcomes and treatment responses

• Develop multiparameter assays combining phospho-CD5 detection with other T-cell signaling markers

• Create standardized protocols for phospho-CD5 assessment in clinical specimens

Ultimately, understanding the regulation and function of CD5 Y453 phosphorylation could lead to more targeted immunomodulatory therapies with improved efficacy and reduced side effects compared to current broad immunosuppressive approaches .

What advanced phosphoproteomic approaches could enhance our understanding of CD5 Y453 phosphorylation in T-cell signaling networks?

Advanced phosphoproteomic technologies offer powerful approaches to deepen our understanding of CD5 Y453 phosphorylation within the broader context of T-cell signaling networks:

Mass Spectrometry-Based Approaches:

• Quantitative Phosphoproteomics:

  • Use stable isotope labeling (SILAC) or tandem mass tag (TMT) labeling to compare phosphorylation profiles

  • Analyze temporal dynamics of CD5 Y453 phosphorylation alongside other signaling molecules

  • Study stimulation-dependent changes in CD5 interaction partners using proximity labeling approaches

• Phospho-Site Specific Analysis:

  • Employ parallel reaction monitoring (PRM) or multiple reaction monitoring (MRM) for targeted quantification of CD5 phosphorylation sites

  • Compare stoichiometry of phosphorylation across all CD5 tyrosine residues

  • Investigate co-occurrence patterns of multiple phosphorylation events on single CD5 molecules

• Formalin-Fixed Paraffin-Embedded (FFPE) Proteomics:

  • Apply techniques similar to those used in CD5-positive DLBCL studies

  • Analyze archival samples to identify disease-specific CD5 phosphorylation patterns

  • This approach has revealed essential pathways in lymphomas that could inform T-cell malignancy research

Single-Cell Technologies:

• Single-Cell Phospho-Flow Cytometry:

  • Develop high-dimensional panels including phospho-CD5 (Y453)

  • Characterize heterogeneity in CD5 phosphorylation within T-cell subpopulations

  • Correlate CD5 phosphorylation with functional outcomes at single-cell resolution

• Mass Cytometry (CyTOF):

  • Create phospho-CD5 specific antibodies compatible with metal-labeling

  • Integrate into panels with 30-40 other markers to provide comprehensive signaling profiles

  • Analyze rare cell populations that may exhibit unique CD5 phosphorylation patterns

Spatial Analysis Technologies:

• Imaging Mass Cytometry:

  • Visualize phospho-CD5 distribution within tissues with subcellular resolution

  • Study spatial relationships between phospho-CD5+ cells and other immune components

  • Map phospho-CD5 dynamics in lymphoid tissues during immune responses

• Proximity Ligation Assay (PLA):

  • Detect protein-protein interactions involving phospho-CD5 in situ

  • Visualize associations between phospho-CD5 and putative binding partners (CBL, CSK)

  • Analyze the spatial organization of CD5 signaling complexes at the immunological synapse

Computational Integration:

• Network Analysis:

  • Integrate phosphoproteomic data into signaling network models

  • Identify feedback loops and cross-talk involving CD5 phosphorylation

  • Predict the systems-level impact of perturbing CD5 phosphorylation

• Machine Learning Approaches:

  • Develop algorithms to identify patterns in phosphoproteomic data

  • Predict functional outcomes based on CD5 phosphorylation patterns

  • Classify patient samples based on phospho-signatures including CD5 Y453